DiscoverKeeping Current CMEConsiderations for Shared Decision-Making on the Use of Anti-Amyloid Therapies in Clinical Practice
Considerations for Shared Decision-Making on the Use of Anti-Amyloid Therapies in Clinical Practice

Considerations for Shared Decision-Making on the Use of Anti-Amyloid Therapies in Clinical Practice

Update: 2025-09-12
Share

Description

What you need to know to help patients and families decide about amyloid-targeting therapies for early-stage Alzheimer’s disease.

Credit available for this activity expires: 9/8/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002882?ecd=bdc_podcast_libsyn_mscpedu

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Considerations for Shared Decision-Making on the Use of Anti-Amyloid Therapies in Clinical Practice

Considerations for Shared Decision-Making on the Use of Anti-Amyloid Therapies in Clinical Practice